Clinical Trial Update: Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating early rivaroxaban for patients with acute ischemic stroke or transient ischemic attack and atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: Cerebral Infarction, TIA | Phase 4 | Status: COMPLETED